SCHEMBL4938271

SCHEMBL4938271

CC(=O)Oc1ccc(C(=O)Nc2ncc(CCS(C)(=O)=O)s2)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCD O00767 10/20 0.48
STAT3 P40763 1/20 0.44
CPT1A P50416 2/20 0.42
CPT1B Q92523 2/20 0.42
SMN1; SMN2 Q16637 5/20 0.41
MEN1 O00255 2/20 0.41
HTT P42858 2/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 5/20 0.41
TP53 P04637 3/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 3/20 0.41
NPC1 O15118 2/20 0.41
CYP2D6 P10635 2/20 0.41
RAB9A P51151 2/20 0.41
CYP3A4 P08684 2/20 0.40
LMNA P02545 2/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10114592 0.82 SCD (0.48) SCDSTAT3CPT1ACPT1BSMN1; SMN2
SCHEMBL4938820 0.82 SCD (0.40) SCDCPT1ACPT1BSMN1; SMN2MEN1
SCHEMBL4932516 0.81 ALDH1A1 (0.45) SCDCPT1ACPT1BSMN1; SMN2KMT2A
SCHEMBL4757218 0.72 STAT3 (0.48) SCDSTAT3SMN1; SMN2MEN1HTT
SCHEMBL10114325 0.71 LMNA (0.39) SCDSTAT3CPT1ACPT1BSMN1; SMN2
SCHEMBL10114568 0.71 TOP1 (0.44) STAT3SMN1; SMN2MEN1HTTKMT2A
SCHEMBL4756613 0.70 SCD (0.38) SCDSTAT3CPT1ACPT1BSMN1; SMN2
SCHEMBL4937296 0.69 TOP1 (0.46) SCDSTAT3SMN1; SMN2MEN1HTT
SCHEMBL5835971 0.68 CDK2 (0.49) SMN1; SMN2MEN1HTTKMT2AL3MBTL1
SCHEMBL10114566 0.68 ALDH1A1 (0.45) STAT3SMN1; SMN2MEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
WO-2009035788-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. (US) 2009-03-19 WO disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SCD 1845/4885STAT3 63/4885CPT1A 1322/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SCD 1845/4885STAT3 63/4885CPT1A 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.